The FDA initially declared the tirzepatide shortage over in October, but the Outsourcing Facilities Association, a trade group for compounding pharmacists, sued, claiming the drug was still in ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

BofA Securities maintained an Underperform rating on shares of Hims & Hers Health, Inc. (NYSE:HIMS) with a steady price ...

Get 5 New Stock Recommendations Every Week As expected by many, Eli Lilly And Co LLY filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and ...

THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication ...

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...

Strategic outsourcing can be a bulwark for companies, helping to guard against the full effects of a challenging economy.

The company highlights that existing FDA-approved formulations lack attributes that would necessitate compounding, while the ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.

Lilly on Wednesday filed a motion to intervene in a lawsuit brought by compounding industry group the Outsourcing Facilities Association (OFA) and compounder FarmaKeio Custom Compounding in U.S ...

The FDA declined to comment. The Outsourcing Facilities Association, which brought the lawsuit along with a Texas compounding pharmacy did not immediately respond to requests for comment.

In a Citizen Petition posted on Regulations.gov, Novo Nordisk (NVO) noted that the Outsourcing Facilities Association, or OFA, has nominated liraglutide be added to their list of bulk drug ...